Thursday, September 9, 2010
Resource Center: Special populations
Results 1 - 10 of 53
Search Results
Description:
Discussing the psychosocial aspects of treatment in patients receiving Buprenorphine/Naloxone
Source:
Physician Clinical Support System (PCSS)
Tags:
Alternative Treatments for Adolescents
Description:
Describes alternatives to buprenorphine treatment for adolescents, both medication and medication-free options. Alternate Treatments for Adolescents
Suboxone® and Pregnancy -- What You Need to Know (en Español)
Description:
This patient handout sheet explains concerns and risks for buprenorphine treatment of patients who are or wish to become pregnant. Suboxone y el embarazo – que usted necesita saber
Abusar la heroína o los analgésicos recetados mientras usted está embarazada es muy peligroso –
Tags:
Special Problems of Adolescents with Opioid Use Disorders
Description:
Details the roots of adolescent opioid use disorders and additional needs of this population. Roots of Adolescent Opioid Use and Abuse
Tags:
Suboxone® and Pregnancy -- What You Need to Know
Description:
This patient handout sheet explains concerns and risks for buprenorphine treatment of patients who are or wish to become pregnant.
Tags:
Description:
Offers recommendations for screening and assessment of adolescents as and discusses referrals, legal issues, and the juvenile justice system.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Tags:
Description:
This survey of 375 physicians found that confidence addressing drug problems was positively associated with having a buprenorphine waiver.
Source:
Journal of General Internal Medicine, 2007
Description:
Guideline document designed to aid treatment providers deliver better services to elderly patients with substance use disorders.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Tags:
Description:
The TIP 32 aims to help treatment providers design and deliver better services to adolescent clients with substance use disorders.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Tags:
Description:
This form provides a list of important considerations when determining whether a methadone patient is a candidate for transfer to buprenorphine treatment, including social, medical, and psychiatric history.
Source:
Colleen LaBelle, RN/Boston Medical Center
Tags:
- Home
- Forums
- Training/CME
- Resources
- How-To Guides
- All How-To Guides
- Get Started Prescribing Buprenorphine
- Assess and Treat Patients with Comorbid Health Issues
- Conduct Buprenorphine Induction
- Establish and Manage a Buprenorphine Practice
- Manage Challenging Patients
- Comply with Rules, Regulations, and Recordkeeping
- Understand Insurance and Billing Issues
- Screen for Substance Abuse
- Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
- Your Bup Site!
Current search
[×]
Topics
: Special populationsRefine your results
Click a term to refine your current search.
Topics
: all » Special populationsCommonly Used Forms
Patient Handouts
- Pregnancy (2)
- En Español (1)
- Resources for family members (1)
Physician stage in practice
- Just became waivered (39)
- Experienced prescriber (31)
- Setting up a practice (28)
- Need to refer (12)
- Becoming waivered (4)
Resource Type
Tags
- Addiction (16)
- Adolescents (12)
- Assessment (7)
- Behavioral therapy (1)
- Cancer (1)
- Comorbidities (12)
- Complicated patients (14)
- Complications (3)
- Consent (3)
- Contract (1)
- Cost of treatment (1)
- DEA (1)
- Dependence (8)
- Detoxification (2)
- Diagnosis (3)
- Discontinuation (2)
- Dosing (4)
- Drug interactions (3)
- DSM (1)
- Elderly patients (4)
- Expert panel (1)
- Hepatitis (5)
- Heroin (1)
- HIV/AIDS (7)
- Induction (3)
- Locator (2)
- Maintenance (4)
- Methadone (5)
- Older adults (2)
- Overdose (1)
- Oxycodone (2)
- Pain (9)
- Pharmacology (4)
- Pharmacotherapy (1)
- Pharmacy (1)
- Polysubstance use (5)
- Precautions (4)
- Pregnant (8)
- Psychiatric (6)
- Psychosocial (2)
- Referral (1)
- Relapse (3)
- Risk factors (1)
- Rural (3)
- Screening (5)
- Side effects (2)
- Special populations (38)
- Suboxone (6)
- Symptoms (1)
- Tapering (1)
- Tolerance (1)
- Waiver (1)
- Withdrawal (5)

